| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1048721415 |
| P356 | DOI | 10.1186/1475-2875-13-354 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1186/1475-2875-13-354 |
| P8608 | Fatcat ID | release_nha5p47qsnfdnn3aptqfneh45u |
| P932 | PMC publication ID | 4164820 |
| P698 | PubMed publication ID | 25192715 |
| P5875 | ResearchGate publication ID | 265395260 |
| P50 | author | Charles C. Kim | Q37383308 |
| P2093 | author name string | Alyssa Baccarella | |
| Brian W Huang | |||
| Mary F Fontana | |||
| P2860 | cites work | Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcome | Q21032453 |
| Proinflammatory responses by glycosylphosphatidylinositols (GPIs) of Plasmodium falciparum are mainly mediated through the recognition of TLR2/TLR1 | Q24632173 | ||
| The role of animal models for research on severe malaria | Q27348351 | ||
| Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: cell signaling receptors, glycosylphosphatidylinositol (GPI) structural requirement, and regulation of GPI activity | Q28579420 | ||
| Gaps in the childhood malaria burden in Africa: cerebral malaria, neurological sequelae, anemia, respiratory distress, hypoglycemia, and complications of pregnancy | Q30681939 | ||
| Murine cerebral malaria development is independent of toll-like receptor signaling | Q33375007 | ||
| The murine cerebral malaria phenomenon | Q33592955 | ||
| Relative levels of IL4 and IFN-gamma in complicated malaria: association with IL4 polymorphism and peripheral parasitemia | Q39510149 | ||
| Residual neurologic sequelae after childhood cerebral malaria | Q39550838 | ||
| Unc93B1 biases Toll-like receptor responses to nucleic acid in dendritic cells toward DNA- but against RNA-sensing | Q39849800 | ||
| Delayed cerebellar ataxia: A rare self limiting complication of plasmodium falciparum malaria. | Q40236900 | ||
| Delayed cerebellar ataxia complicating falciparum malaria: a clinical study of 74 patients | Q40700518 | ||
| Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin | Q41912941 | ||
| Recognition of Borrelia burgdorferi, the Lyme disease spirochete, by TLR7 and TLR9 induces a type I IFN response by human immune cells | Q43268950 | ||
| Malaria blood stage parasites activate human plasmacytoid dendritic cells and murine dendritic cells through a Toll-like receptor 9-dependent pathway | Q47810239 | ||
| Interleukin-10 modulates susceptibility in experimental cerebral malaria. | Q47823424 | ||
| MyD88-dependent activation of dendritic cells and CD4(+) T lymphocytes mediates symptoms, but is not required for the immunological control of parasites during rodent malaria. | Q47833974 | ||
| Toll-like receptor modulation of murine cerebral malaria is dependent on the genetic background of the host | Q47848814 | ||
| Differential interleukin-10 expression in interferon regulatory factor-1 deficient mice during Plasmodium berghei blood-stage infection | Q47870834 | ||
| Plasma interleukin-10:Tumor necrosis factor (TNF)-alpha ratio is associated with TNF promoter variants and predicts malarial complications | Q47872640 | ||
| Neuropathogenesis of human and murine malaria | Q47937036 | ||
| Cerebral malaria: in praise of epistemes | Q47938191 | ||
| Cerebral malaria: human versus mouse studies | Q47938712 | ||
| Vascular clogging, mononuclear cell margination, and enhanced vascular permeability in the pathogenesis of human cerebral malaria | Q48011107 | ||
| Profiles of cytokine production in relation with susceptibility to cerebral malaria | Q48021685 | ||
| Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria | Q48030499 | ||
| Clusters of cytokines determine malaria severity in Plasmodium falciparum-infected patients from endemic areas of Central India | Q48031375 | ||
| The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria | Q48033393 | ||
| Pathological role of Toll-like receptor signaling in cerebral malaria. | Q48036899 | ||
| Cutting edge: TLR9 and TLR2 signaling together account for MyD88-dependent control of parasitemia in Trypanosoma cruzi infection | Q58845195 | ||
| Parasite-derived plasma microparticles contribute significantly to malaria infection-induced inflammation through potent macrophage stimulation | Q33618034 | ||
| Protein-DNA complex is the exclusive malaria parasite component that activates dendritic cells and triggers innate immune responses | Q33776347 | ||
| The nucleosome (histone-DNA complex) is the TLR9-specific immunostimulatory component of Plasmodium falciparum that activates DCs. | Q33936854 | ||
| Gamma delta T-cell function in pathogenesis of cerebral malaria in mice infected with Plasmodium berghei ANKA. | Q34000104 | ||
| Cytokines in the pathogenesis of and protection against malaria | Q34174462 | ||
| Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor | Q34292144 | ||
| TLR11 activation of dendritic cells by a protozoan profilin-like protein. | Q34414638 | ||
| Genetic susceptibility to systemic lupus erythematosus protects against cerebral malaria in mice | Q34509018 | ||
| The relevance of non-human primate and rodent malaria models for humans | Q34585958 | ||
| Therapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malaria | Q34621573 | ||
| Beta interferon suppresses the development of experimental cerebral malaria | Q34740075 | ||
| Association of cytokine and Toll-like receptor gene polymorphisms with severe malaria in three regions of Cameroon | Q35060420 | ||
| Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria | Q35216393 | ||
| Tumor necrosis factor ? in the pathogenesis of cerebral malaria | Q35541025 | ||
| Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9. | Q35629356 | ||
| Murine AIDS protects mice against experimental cerebral malaria: down-regulation by interleukin 10 of a T-helper type 1 CD4+ cell-mediated pathology | Q35682162 | ||
| Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration | Q35835353 | ||
| The burden of the neurocognitive impairment associated with Plasmodium falciparum malaria in sub-saharan Africa. | Q35872630 | ||
| TLR9 and MyD88 are crucial for the development of protective immunity to malaria | Q35936144 | ||
| Cerebrospinal fluid cytokine levels and cognitive impairment in cerebral malaria. | Q36477981 | ||
| Protozoan encounters with Toll-like receptor signalling pathways: implications for host parasitism. | Q36655907 | ||
| Plasma IP-10, apoptotic and angiogenic factors associated with fatal cerebral malaria in India | Q36688537 | ||
| Malaria: mechanisms of erythrocytic infection and pathological correlates of severe disease | Q37014714 | ||
| Two ways to survive infection: what resistance and tolerance can teach us about treating infectious diseases | Q37301031 | ||
| Toll-like receptor 7 mediates early innate immune responses to malaria | Q37336051 | ||
| Serum levels of the proinflammatory cytokines interleukin-1 beta (IL-1beta), IL-6, IL-8, IL-10, tumor necrosis factor alpha, and IL-12(p70) in Malian children with severe Plasmodium falciparum malaria and matched uncomplicated malaria or healthy con | Q37523995 | ||
| Neurological sequelae of cerebral malaria in children | Q37601100 | ||
| Cerebral malaria: why experimental murine models are required to understand the pathogenesis of disease | Q37661151 | ||
| Rethinking cerebral malaria pathology | Q37770899 | ||
| Caspase-1 activation of interleukin-1β (IL-1β) and IL-18 is dispensable for induction of experimental cerebral malaria | Q38284130 | ||
| Induction of experimental cerebral malaria is independent of TLR2/4/9. | Q39171649 | ||
| Interferon-gamma is essential for the development of cerebral malaria | Q39413194 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | malaria | Q12156 |
| toll-like receptor | Q408004 | ||
| cerebral malaria | Q2822915 | ||
| P304 | page(s) | 354 | |
| P577 | publication date | 2014-09-05 | |
| P1433 | published in | Malaria Journal | Q15749954 |
| P1476 | title | Loss of Toll-like receptor 7 alters cytokine production and protects against experimental cerebral malaria | |
| P478 | volume | 13 |
| Q40063063 | Blood-stage malaria of Plasmodium chabaudi induces differential Tlr expression in the liver of susceptible and vaccination-protected Balb/c mice |
| Q64266236 | Characterization of Plasmodium berghei Homologues of T-cell Immunomodulatory Protein as a New Potential Candidate for Protecting against Experimental Cerebral Malaria |
| Q56376508 | Genetic analysis of cerebral malaria in the mouse model infected with Plasmodium berghei |
| Q38937016 | Genetic predisposition of variants in TLR2 and its co-receptors to severe malaria in Odisha, India |
| Q63408452 | Human TLR8 Senses RNA From -Infected Red Blood Cells Which Is Uniquely Required for the IFN-γ Response in NK Cells |
| Q40155612 | Hydrogen sulfide protects against the development of experimental cerebral malaria in a C57BL/6 mouse model |
| Q35904007 | Mouse Models of Uncomplicated and Fatal Malaria. |
| Q41106752 | Myeloid expression of the AP-1 transcription factor JUNB modulates outcomes of type 1 and type 2 parasitic infections. |
| Q60947070 | Parasite Recognition and Signaling Mechanisms in Innate Immune Responses to Malaria |
| Q42699736 | Pathogenesis of Plasmodium berghei ANKA infection in the gerbil (Meriones unguiculatus) as an experimental model for severe malaria |
| Q36281728 | Phagosomal Acidification Prevents Macrophage Inflammatory Cytokine Production to Malaria, and Dendritic Cells Are the Major Source at the Early Stages of Infection: IMPLICATION FOR MALARIA PROTECTIVE IMMUNITY DEVELOPMENT |
Search more.